Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Frederic N. Ello"'
Autor:
Frederic N. Ello, Esaie K. Soya, N'douba A. Kassi, Patrick A. Coffie, Gisele A. Koaukou, Melaine C. Mossou, Doumbia Adama, Icklo Coulibaly, Eboi Ehui, Aristophane Tanon, Serge P. Eholie
Publikováno v:
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e6 (2021)
Background: With success and effective long-term antiretroviral treatment (ART), HIV-infected patients live longer and frequently developed non-communicable diseases (NCDs). Few studies have been conducted in low-income countries, particularly in Wes
Externí odkaz:
https://doaj.org/article/96538b7e93b84dc6b0c804eaf6f4bb93
Autor:
Aristophane Tanon, Frederic N. Ello, Doumbia Adama, N'douba A. Kassi, Icklo Coulibaly, Esaie K. Soya, Gisele A. Koaukou, Eboi Ehui, Patrick A. Coffie, Serge Eholié, Melaine C. Mossou
Publikováno v:
Southern African Journal of Infectious Diseases
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e6 (2021)
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e6 (2021)
Background: With success and effective long-term antiretroviral treatment (ART), HIV-infected patients live longer and frequently developed non-communicable diseases (NCDs). Few studies have been conducted in low-income countries, particularly in Wes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37beb9fda03c05a97c96c8d8924586a1
http://europepmc.org/articles/PMC8378198
http://europepmc.org/articles/PMC8378198
Autor:
Frederic N. Ello, Arsène Hema, Adrien Sawadogo, Patrick A. Coffie, Serge Eholié, Daouda K. Minta
Publikováno v:
Tropical Medicine & International Health. 22:1186-1195
Introduction Cotrimoxazole (CTX) should be given to all HIV-infected adults with mild or severe HIV disease or those with CD4 counts below 350/mm3 according to 2006 WHO guidelines. We assessed the impact of CTX prophylaxis on the risk of malaria epis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a912c6003a8f2dbca87e689942d5a5c3
https://doi.org/10.1111/tmi.12919
https://doi.org/10.1111/tmi.12919
Autor:
Roland Landman, Thomas-d'Aquin Toni, Coumba Toure-Kane, Daouda K. Minta, Gilles Peytavin, Frederic N. Ello, Eugène Messou, Almoustapha Issiaka Maiga, Jacques Zoungrana, Laure-Amelie de Monteynard, Mamadou Cisse, Ismael Diallo, Mouhamadou Baïla Diallo, Adrien Sawadogo, Xavier Anglaret, Lassana Sangaré, Amani Anzian, Malika Congo-Ouédraogo, Sophie Karcher, Jérome Le Carrou, Guillaume Bado, Serge Eholié, Marie-Laure Chaix, P M Girard, Audrey Gabassi, Delphine Gabillard, Aïda Benalycherif, Raoul Moh, Joseph Y Drabo, Moussa Seydi
Publikováno v:
The Lancet HIV
The Lancet HIV, 2019, 6 (11), pp.e750-e759. ⟨10.1016/s2352-3018(19)30228-0⟩
The Lancet HIV, 2019, 6 (11), pp.e750-e759. ⟨10.1016/s2352-3018(19)30228-0⟩
BACKGROUND: The decision about whether to switch to third-line antiretroviral therapy (ART) in patients with treatment failure on second-line therapy is difficult in settings with little access to genotypic resistance testing. In this study, we used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c801e7b870860a82abc58c17f7c4e6
http://hdl.handle.net/20.500.12278/38733
http://hdl.handle.net/20.500.12278/38733
Autor:
Alain Kassi, François Eba Aoussi, Gisèle Affoué Kouakou, C. Konin, Eboi Ehui, Doumbia Adama, Aka Rigobert Kakou, Dine Mourtada, Lidaw Déassoua Bawe, Aristophane Tanon, Frederic N. Ello, Serge Eholié, Chrysostome Melaine Mossou
Publikováno v:
Pan African Medical Journal. 31
In HIV-infected patients thromboembolic disease is a complication linked to heightened risk. In Ivory Coast no study has been conducted on HIV-infected patients treated in HIV Services. The aim of our study is to describe HIV-associated thromboemboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6c1bba64e50373ebdc2dd94d55d6381
https://doi.org/10.11604/pamj.2018.31.224.13774
https://doi.org/10.11604/pamj.2018.31.224.13774
Autor:
Tessa Lennemann, Pierre-Marie Girard, Alain Pruvost, Raoul Moh, Xavier Anglaret, Lucas Maganga, Friedrich von Massow, Jimson Mgaya, Serge Eholié, Frederic N. Ello, Christine Danel, Michael Hoelscher, Ralph Zuhse, Arne Kroidl, Elmar Saathoff
Publikováno v:
AIDS
AIDS, Lippincott, Williams & Wilkins, 2017, 31 (4), pp.501-509. ⟨10.1097/QAD.0000000000001362⟩
AIDS. Official journal of the international AIDS Society
AIDS. Official journal of the international AIDS Society, 2017, 31 (4), pp.501-509. ⟨10.1097/QAD.0000000000001362⟩
AIDS (London, England)
AIDS, Lippincott, Williams & Wilkins, 2017, 31 (4), pp.501-509. ⟨10.1097/QAD.0000000000001362⟩
AIDS. Official journal of the international AIDS Society
AIDS. Official journal of the international AIDS Society, 2017, 31 (4), pp.501-509. ⟨10.1097/QAD.0000000000001362⟩
AIDS (London, England)
Supplemental Digital Content is available in the text
Objective: Use of zidovudine (ZDV) in antiretroviral therapy is limited by toxicity and twice daily (b.i.d.) dosing. Fozivudine (FZD) is a ZDV prodrug, which is activated intracellularly to Z
Objective: Use of zidovudine (ZDV) in antiretroviral therapy is limited by toxicity and twice daily (b.i.d.) dosing. Fozivudine (FZD) is a ZDV prodrug, which is activated intracellularly to Z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57549cfdbc42d54d9f73f9d4111a07c2
https://hal.archives-ouvertes.fr/hal-01600206
https://hal.archives-ouvertes.fr/hal-01600206